Revispas Drop
By Revispas
15ml Drop in a Packet

Composition
Simethicone(NA)

Manufacturer - Ravenbhel Pharmaceuticals Pvt Ltd
Ravenbhel Pharmaceuticals (P) Ltd., 7, Baba Budha Ji Avenue, G.T. Road, Amritsar-Punjab (143001)

Expires on or after
August, 2025

liver
Caution should be taken when considering the use of Revispas Drop in individuals with liver disease. It is important to consult with a healthcare provider before using this product in such cases. Limited information is currently available regarding the safety and efficacy of Revispas Drop in relation to liver issues. Therefore, it is advisable to seek guidance from a medical professional to ensure the appropriate and safe usage of this product.

kidney
Limited information exists regarding the use of Revispas Drop in individuals with kidney disease. Consult your doctor for guidance.

alcohol
Consult your doctor when consuming alcohol with Revispas Drop.

driving
When taking Revispas Drop, it is unlikely to impact your driving ability. It is essential to be cautious while driving to ensure safety on the road.

pregnancy
Revispas Drop is considered safe for use during pregnancy based on animal studies showing minimal harm to the baby; limited human studies are available.

breastfeeding
Revispas Drop is considered safe during breastfeeding based on limited human data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | Poly(Dimethylsiloxane) |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | Anti-foaming agent |
₹28.28
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024